Genetic contribution of the leukotriene pathway to coronary artery disease

Human Genetics

Volumn 129, Issue 6, 2011, Pages 617-627

  Hartiala, Jaana ^a   Li, Dalin ^a   Conti, David V ^a   Vikman, Susanna ^a   Patel, Yesha ^a   Wilson Tang, W H ^b   Brennan, Marie Louise ^b   Newman, John W ^c   Stephensen, Charles B ^c   Armstrong, Patrice ^c   Hazen, Stanley L ^b   Allayee, Hooman ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CYSTEINYL LEUKOTRIENE RECEPTOR 1; CYSTEINYL LEUKOTRIENE RECEPTOR 2; CYTOCHROME P450; CYTOCHROME P450 4F3; GLUTATHIONE TRANSFERASE; LEUKOTRIENE; LEUKOTRIENE A4 HYDROLASE; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR; LEUKOTRIENE B4 RECEPTOR 1; LEUKOTRIENE B4 RECEPTOR 2; LEUKOTRIENE C4 SYNTHASE; LEUKOTRIENE RECEPTOR; MICROSOMAL GLUTATHIONE S TRANSFERASE 1; MICROSOMAL GLUTATHIONE S TRANSFERASE 2; MICROSOMAL GLUTATHIONE S TRANSFERASE 3; OXIDOREDUCTASE; PHOSPHOLIPASE A2 GROUP IV; PHOSPHOLIPASE A2 GROUP IVA; PHOSPHOLIPASE A2 GROUP V; PROSTAGLANDIN REDUCTASE 1 ISOFORM 1; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; ALLELE; ARTICLE; BIOSYNTHESIS; CATALYSIS; CAUCASIAN; CHEMOTAXIS; CORONARY ARTERY DISEASE; FEMALE; GENE FUNCTION; GENETIC VARIABILITY; HAPLOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MORTALITY; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CORONARY ARTERY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LEUKOTRIENES; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79959750245     PISSN: 03406717     EISSN: 14321203     Source Type: Journal    
DOI: 10.1007/s00439-011-0963-3     Document Type: Article

References (45)

1. N Ahluwalia AY Lin AM Tager IE Pruitt TJ Anderson F Kristo D Shen AR Cruz M Aikawa AD Luster RE Gerszten 2007 Inhibited aortic aneurysm formation in BLT1-deficient mice J Immunol 179 691 697 17579092 1:CAS:528: DC%2BD2sXmsF2gu7o%3D (Pubitemid 46986588)
2. RJ Aiello PA Bourassa S Lindsey W Weng A Freeman HJ Showell 2002 Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice Arterioscler Thromb Vasc Biol 22 443 449 11884288 10.1161/hq0302.105593 1:CAS:528:DC%2BD38XitFGhu70%3D (Pubitemid 34218752)
3. H Allayee A Baylin J Hartiala H Wijesuriya M Mehrabian AJ Lusis H Campos 2008 Nutrigenetic association of the 5-lipoxygenase gene with myocardial infarction Am J Clin Nutr 88 934 940 18842779 1:CAS:528:DC%2BD1cXht1Gks7jJ
4. TL Assimes JW Knowles JR Priest A Basu KA Volcik A Southwick HK Tabor J Hartiala H Allayee ML Grove R Tabibiazar S Sidney SP Fortmann A Go M Hlatky C Iribarren E Boerwinkle R Myers N Risch T Quertermous 2008 Common polymorphisms of ALOX5 and ALOX5AP and risk of coronary artery disease Hum Genet 123 399 408 18369664 10.1007/s00439-008-0489-5 1:CAS:528:DC%2BD1cXks1Gjt70%3D
5. M Back GK Hansson 2006 Leukotriene receptors in atherosclerosis Ann Med 38 493 502 17101540 10.1080/07853890600982737 (Pubitemid 44764437)
6. S Bevan M Dichgans HE Wiechmann A Gschwendtner T Meitinger HS Markus 2008 Genetic variation in members of the leukotriene biosynthesis pathway confer an increased risk of ischemic stroke: a replication study in two independent populations Stroke 39 1109 1114 18323512 10.1161/STROKEAHA.107.491969 1:CAS:528:DC%2BD1cXjtlSqtrk%3D (Pubitemid 351440677)
7. T Bhattacharyya SJ Nicholls EJ Topol R Zhang X Yang D Schmitt X Fu M Shao DM Brennan SG Ellis ML Brennan H Allayee AJ Lusis SL Hazen 2008 Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk JAMA 299 1265 1276 18349088 10.1001/jama.299.11.1265 1:CAS:528:DC%2BD1cXjsVOmtb8%3D (Pubitemid 351439073)
8. Burdon KP, Rudock ME, Lehtinen AB, Langefeld CD, Bowden DW, Register TC, Liu Y, Freedman BI, Carr JJ, Hedrick CC, Rich SS (2010) Human lipoxygenase pathway gene variation and association with markers of subclinical atherosclerosis in the diabetes heart study. Mediators Inflamm 2010:170153
9. CS Carlson PJ Heagerty AS Nord DK Pritchard J Ranchalis JM Boguch H Duan TS Hatsukami SM Schwartz MJ Rieder DA Nickerson GP Jarvik 2007 TagSNP evaluation for the association of 42 inflammation loci and vascular disease: evidence of IL6, FGB, ALOX5, NFKBIA, and IL4R loci effects Hum Genet 121 65 75 17115186 10.1007/s00439-006-0289-8 1:CAS:528:DC%2BD2sXhsFCgsL4%3D (Pubitemid 46421142)
10. DR Crosslin SH Shah SC Nelson CS Haynes JJ Connelly S Gadson PJ Goldschmidt-Clermont JM Vance J Rose CB Granger D Seo SG Gregory WE Kraus ER Hauser 2009 Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis Hum Genet 125 217 229 19130089 10.1007/s00439-008-0619-0 1:CAS:528:DC%2BD1MXitVOrtrg%3D
11. PI de Bakker R Yelensky I Pe'er SB Gabriel MJ Daly D Altshuler 2005 Efficiency and power in genetic association studies Nat Genet 37 1217 1223 16244653 10.1038/ng1669 (Pubitemid 41568704)
12. JH Dwyer H Allayee KM Dwyer J Fan H Wu R Mar AJ Lusis M Mehrabian 2004 Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis N Engl J Med 350 29 37 14702425 10.1056/NEJMoa025079 1:CAS:528:DC%2BD2cXhtFGhtw%3D%3D (Pubitemid 38032181)
13. P Gonzalez JR Reguero I Lozano C Moris E Coto 2007 A functional Sp1/Egr1-tandem repeat polymorphism in the 5-lipoxygenase gene is not associated with myocardial infarction Int J Immunogenet 34 127 130 17373938 10.1111/j.1744-313X.2007.00671.x 1:CAS:528:DC%2BD2sXktVOjtrw%3D (Pubitemid 46435098)
14. A Helgadottir A Manolescu G Thorleifsson S Gretarsdottir H Jonsdottir U Thorsteinsdottir NJ Samani G Gudmundsson SF Grant G Thorgeirsson S Sveinbjornsdottir EM Valdimarsson SE Matthiasson H Johannsson O Gudmundsdottir ME Gurney J Sainz M Thorhallsdottir M Andresdottir ML Frigge EJ Topol A Kong V Gudnason H Hakonarson JR Gulcher K Stefansson 2004 The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke Nat Genet 36 233 239 14770184 10.1038/ng1311 1:CAS:528: DC%2BD2cXhsFOnsL4%3D (Pubitemid 38282747)
15. A Helgadottir S Gretarsdottir D St Clair A Manolescu J Cheung G Thorleifsson A Pasdar SF Grant LJ Whalley H Hakonarson U Thorsteinsdottir A Kong J Gulcher K Stefansson MJ MacLeod 2005 Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population Am J Hum Genet 76 505 509 15640973 10.1086/428066 1:CAS:528: DC%2BD2MXhsFKrtr4%3D (Pubitemid 40250529)
16. A Helgadottir A Manolescu A Helgason G Thorleifsson U Thorsteinsdottir DF Gudbjartsson S Gretarsdottir KP Magnusson G Gudmundsson A Hicks T Jonsson SF Grant J Sainz SJ O'Brien S Sveinbjornsdottir EM Valdimarsson SE Matthiasson AI Levey JL Abramson MP Reilly V Vaccarino ML Wolfe V Gudnason AA Quyyumi EJ Topol DJ Rader G Thorgeirsson JR Gulcher H Hakonarson A Kong K Stefansson 2006 A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction Nat Genet 38 68 74 16282974 10.1038/ng1692 1:CAS:528:DC%2BD2MXhtlCmtr7F (Pubitemid 43011884)
17. EA Heller E Liu AM Tager S Sinha JD Roberts SL Koehn P Libby ER Aikawa JQ Chen P Huang MW Freeman KJ Moore AD Luster RE Gerszten 2005 Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment Circulation 112 578 586 16043658 10.1161/CIRCULATIONAHA. 105.545616 (Pubitemid 41060799)
18. DM Iovannisci EJ Lammer L Steiner S Cheng LT Mahoney PH Davis RM Lauer TL Burns 2007 Association between a leukotriene C4 synthase gene promoter polymorphism and coronary artery calcium in young women: the Muscatine Study Arterioscler Thromb Vasc Biol 27 394 399 17110605 10.1161/01.ATV.0000252680. 72734.10 1:CAS:528:DC%2BD2sXjvFGrsA%3D%3D (Pubitemid 46150770)
19. J Jawien M Gajda M Rudling L Mateuszuk R Olszanecki TJ Guzik T Cichocki S Chlopicki R Korbut 2006 Inhibition of five lipoxygenase activating protein (FLAP) by MK-886 decreases atherosclerosis in apoE/LDLR-double knockout mice Eur J Clin Invest 36 141 146 16506957 10.1111/j.1365-2362.2006.01606.x 1:CAS:528:DC%2BD28XjsFSgs7Y%3D (Pubitemid 43341263)
20. J Jawien M Gajda P Wolkow J Zuranska R Olszanecki R Korbut 2008 The effect of montelukast on atherogenesis in apoE/LDLR-double knockout mice J Physiol Pharmacol 59 633 639 18953103 1:CAS:528:DC%2BD1cXht1Krur3O
21. W Koch P Hoppmann JC Mueller A Schomig A Kastrati 2007 No association of polymorphisms in the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a large central European population Genet Med 9 123 129 17304054 10.1097/GIM.0b013e318030c9c5 1:CAS:528:DC%2BD2sXhslCmt7k%3D
22. RN Lemaitre K Rice K Marciante JC Bis TS Lumley KL Wiggins NL Smith SR Heckbert BM Psaty 2009 Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke Atherosclerosis 204 e58 e63 19046748 10.1016/j.atherosclerosis.2008.10.011 1:CAS:528:DC%2BD1MXmtl2lu74%3D
23. JJ Lima S Zhang A Grant L Shao KG Tantisira H Allayee J Wang J Sylvester J Holbrook R Wise ST Weiss K Barnes 2006 Influence of leukotriene pathway polymorphisms on response to montelukast in asthma Am J Respir Crit Care Med 173 379 385 16293801 10.1164/rccm.200509-1412OC 1:CAS:528:DC%2BD28XmslSlurg%3D (Pubitemid 43228324)
24. P Linsel-Nitschke A Gotz A Medack IR Konig P Bruse W Lieb B Mayer K Stark C Hengstenberg M Fischer A Baessler A Ziegler H Schunkert J Erdmann 2008 Genetic variation in the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) is associated with myocardial infarction in the German population Clin Sci (Lond) 115 309 315 10.1042/CS20070468 1:CAS:528:DC%2BD1cXht1Cmsb7M
25. KJ Livak 1999 Allelic discrimination using fluorogenic probes and the 5 nuclease assay Genet Anal 14 143 149 10084106 1:CAS:528:DyaK1MXhvVylsbo%3D (Pubitemid 29095371)
26. KJ Livak 2003 SNP genotyping by the 5-nuclease reaction Methods Mol Biol 212 129 147 12491907 1:CAS:528:DC%2BD38Xptlentbg%3D
27. A Maznyczka P Braund M Mangino NJ Samani 2008 Arachidonate 5-lipoxygenase (5-LO) promoter genotype and risk of myocardial infarction: a case-control study Atherosclerosis 199 328 332 18179798 10.1016/j.atherosclerosis.2007.11.027 1:CAS:528:DC%2BD1cXptVWkt7k%3D
28. M Mehrabian H Allayee 2003 5-Lipoxygenase and atherosclerosis Curr Opin Lipidol 14 447 457 14501583 10.1097/00041433-200310000-00005 1:CAS:528:DC%2BD3sXntlyrtL4%3D (Pubitemid 37297299)
29. M Mehrabian H Allayee J Wong W Shi XP Wang Z Shaposhnik CD Funk AJ Lusis 2002 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice Circ Res 91 120 126 12142344 10.1161/01.RES.0000028008.99774.7F 1:CAS:528:DC%2BD38XlvVCgs7Y%3D (Pubitemid 34827222)
30. M Mehrabian H Allayee J Stockton PY Lum TA Drake LW Castellani M Suh C Armour S Edwards J Lamb AJ Lusis EE Schadt 2005 Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits Nat Genet 37 1224 1233 16200066 10.1038/ng1619 1:CAS:528:DC%2BD2MXhtFGhsL3M (Pubitemid 41568705)
31. M Mehrabian FT Schulthess M Nebohacova LW Castellani Z Zhou J Hartiala J Oberholzer AJ Lusis K Maedler H Allayee 2008 Identification of ALOX5 as a gene regulating adiposity and pancreatic function Diabetologia 51 978 988 18421434 10.1007/s00125-008-1002-3 1:CAS:528:DC%2BD1cXlt1CrsLc%3D
32. SJ Nicholls SL Hazen 2005 Myeloperoxidase and cardiovascular disease Arterioscler Thromb Vasc Biol 25 1102 1111 15790935 10.1161/01.ATV.0000163262. 83456.6d 1:CAS:528:DC%2BD2MXksVWqsLk%3D (Pubitemid 40776595)
33. Nicholls SJ, Tang WH, Scoffone H, Brennan DM, Hartiala J, Allayee H, Hazen SL (2010) Lipoprotein (a) levels and long-term cardiovascular risk in the contemporary era of statin therapy. J Lipid Res
34. M Peters-Golden WR Henderson Jr 2007 Leukotrienes N Engl J Med 357 1841 1854 17978293 10.1056/NEJMra071371 1:CAS:528:DC%2BD2sXht1KitL%2FM (Pubitemid 350044805)
35. H Qiu A Gabrielsen HE Agardh M Wan A Wetterholm CH Wong U Hedin J Swedenborg GK Hansson B Samuelsson G Paulsson-Berne JZ Haeggstrom 2006 Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability Proc Natl Acad Sci USA 103 8161 8166 16698924 10.1073/pnas.0602414103 1:CAS:528:DC%2BD28Xlt1ChtLw%3D (Pubitemid 43801069)
36. B Samuelsson 1983 Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation Science 220 568 575 6301011 10.1126/science.6301011 1:CAS:528:DyaL3sXhvFWrtr0%3D (Pubitemid 13130140)
37. M Sanak M Pierzchalska S Bazan-Socha A Szczeklik 2000 Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma Am J Respir Cell Mol Biol 23 290 296 10970818 1:CAS:528:DC%2BD3cXntVSht7o%3D
38. SH Shah ER Hauser D Crosslin L Wang C Haynes J Connelly S Nelson J Johnson S Gadson CL Nelson D Seo S Gregory WE Kraus CB Granger P Goldschmidt-Clermont LK Newby 2008 ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention Atherosclerosis 201 148 154 18374923 10.1016/j.atherosclerosis.2008.01.011 1:CAS:528:DC%2BD1cXht1Kltr7P
39. R Spanbroek R Grabner K Lotzer M Hildner A Urbach K Ruhling MP Moos B Kaiser TU Cohnert T Wahlers A Zieske G Plenz H Robenek P Salbach H Kuhn O Radmark B Samuelsson AJ Habenicht 2003 Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis Proc Natl Acad Sci USA 100 1238 1243 12552108 10.1073/pnas.242716099 1:CAS:528:DC%2BD3sXhtF2gtbo%3D (Pubitemid 36183986)
40. K Subbarao VR Jala S Mathis J Suttles W Zacharias J Ahamed H Ali MT Tseng B Haribabu 2004 Role of leukotriene B4 receptors in the development of atherosclerosis: potential mechanisms Arterioscler Thromb Vasc Biol 24 369 375 14656734 10.1161/01.ATV.0000110503.16605.15 1:CAS:528:DC%2BD2cXnsFCnsg%3D%3D (Pubitemid 38197592)
41. AK Tsai N Li NQ Hanson MY Tsai W Tang 2009 Associations of genetic polymorphisms of arachidonate 5-lipoxygenase-activating protein with risk of coronary artery disease in a European-American population Atherosclerosis 207 487 491 19596330 10.1016/j.atherosclerosis.2009.06.018 1:CAS:528: DC%2BD1MXhsFSgsL%2FM
42. CN Tymchuk J Hartiala PI Patel M Mehrabian H Allayee 2006 Nonconventional genetic risk factors for cardiovascular disease Curr Atheroscler Rep 8 184 192 16640955 10.1007/s11883-006-0072-2 1:CAS:528:DC%2BD28Xltlalt7o%3D (Pubitemid 43676322)
43. S Vikman RM Brena P Armstrong J Hartiala CB Stephensen H Allayee 2009 Functional analysis of 5-lipoxygenase promoter repeat variants Hum Mol Genet 18 23 4521 4529 19717473 10.1093/hmg/ddp414 1:CAS:528:DC%2BD1MXhtlygs7jO
44. RY Zee S Cheng HH Hegener HA Erlich PM Ridker 2006 Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach Stroke 37 2007 2011 16778124 10.1161/01.STR.0000229905.25080.01 1:CAS:528:DC%2BD28XmvFaksr8%3D (Pubitemid 44309895)
45. E Zintzaras P Rodopoulou N Sakellaridis 2009 Variants of the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and risk of stroke: a HuGE gene-disease association review and meta-analysis Am J Epidemiol 169 523 532 19126581 10.1093/aje/kwn368